Stablix Appoints Eddine Saiah Chief Scientific Officer and Expands Leadership Team
NEW YORK–(BUSINESS WIRE)–Stablix, Inc., a biopharmaceutical company pioneering targeted protein stabilization (TPS) as a novel therapeutic modality, today announced that Eddine Saiah, Ph.D., has joined the company as Chief Scientific Officer. Dr. Saiah is an experienced drug hunter and seasoned leader with over 25 years of experience heading drug discovery, preclinical and early development in … [Read more…]
